Dr. Vogel shared insights on the importance of liver function in treatment decisions, the significance of treatment intent, and the potential of immunotherapy as a downstaging or bridging strategy for liver transplantation. With a wealth of experience, he emphasized the need for careful consideration of patient-specific factors and the management of treatment-related toxicities.
Related Posts
Short Clips from AIOShort Clips from AIOFebruary 27, 2025
Which Androgen Receptor Pathway Inhibitors (ARPI) to Pick for Treatment of Prostate Cancer
Short Clips from AIOShort Clips from AIOFebruary 27, 2025